Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
51,093,635
-
Shares change
-
+859,677
-
Total reported value, excl. options
-
$286,122,600
-
Value change
-
+$4,687,211
-
Put/Call ratio
-
66%
-
Number of buys
-
31
-
Number of sells
-
-28
-
Price
-
$5.60
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q2 2023
77 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q2 2023.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51,093,635 shares
of 55,351,475 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (29,225,579 shares), FMR LLC (5,434,773 shares), HarbourVest Partners LLC (3,512,110 shares), Artal Group S.A. (2,533,045 shares), STATE OF WISCONSIN INVESTMENT BOARD (1,859,165 shares), BlackRock Inc. (1,609,686 shares), VANGUARD GROUP INC (1,484,222 shares), CHI Advisors LLC (1,055,882 shares), PLATINUM INVESTMENT MANAGEMENT LTD (888,335 shares), and 683 Capital Management, LLC (475,000 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.